RYTM (STOCKS)
Rhythm Pharmaceuticals, Inc. Common Stock
$96.000000
-2.470000 (-2.51%)
Prev close: $98.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David P. Meeker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,403.33M
- Employees
- 283
- P/E (TTM)
- -30.96
- P/B (TTM)
- 44.12
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
11
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.82 | $-0.74 | -0.0816 | -11.05% |
|
Jun 2025 (Q2)
|
$-0.75 | $-0.69 | -0.0609 | -8.84% |
|
Mar 2025 (Q1)
|
$-0.81 | $-0.72 | -0.0943 | -13.18% |
|
Dec 2024 (Q4)
|
$-0.72 | $-0.73 | +0.0055 | +0.76% |
Financial Statements
| Revenues | $174.33M |
| Benefits Costs and Expenses | $366.22M |
| Cost Of Revenue | $18.48M |
| Costs And Expenses | $360.54M |
| Gross Profit | $155.86M |
| Nonoperating Income/Loss | -$5.68M |
| Operating Expenses | $342.07M |
| Selling, General, and Administrative Expenses | $175.59M |
| Research and Development | $166.48M |
| Operating Income/Loss | -$186.21M |
| Income/Loss From Continuing Operations After Tax | -$192.33M |
| Income/Loss From Continuing Operations Before Tax | -$191.89M |
| Income Tax Expense/Benefit | $438.00K |
| Net Income/Loss | -$192.33M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$192.33M |
| Net Income/Loss Available To Common Stockholders, Basic | -$197.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $5.39M |
| Preferred Stock Dividends And Other Adjustments | $5.39M |
| Basic Earnings Per Share | -$3.10 |
| Diluted Earnings Per Share | -$3.10 |
| Basic Average Shares | 64,548,463 |
| Diluted Average Shares | 64,548,463 |
| Assets | $506.87M |
| Current Assets | $494.80M |
| Cash | $416.10M |
| Inventory | $22.11M |
| Other Current Assets | $56.60M |
| Noncurrent Assets | $12.07M |
| Fixed Assets | $237.00K |
| Other Non-current Assets | $11.84M |
| Liabilities | $211.19M |
| Current Liabilities | $104.27M |
| Accounts Payable | $13.63M |
| Other Current Liabilities | $90.64M |
| Noncurrent Liabilities | $106.92M |
| Equity | $148.82M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $148.82M |
| Temporary Equity | $146.87M |
| Temporary Equity Attributable To Parent | $146.87M |
| Liabilities And Equity | $506.87M |
| Net Cash Flow From Operating Activities | -$109.13M |
| Net Cash Flow From Operating Activities, Continuing | -$109.13M |
| Net Cash Flow From Investing Activities | -$146.34M |
| Net Cash Flow From Investing Activities, Continuing | -$146.34M |
| Net Cash Flow From Financing Activities | $259.24M |
| Net Cash Flow From Financing Activities, Continuing | $259.24M |
| Net Cash Flow | $3.77M |
| Net Cash Flow, Continuing | $3.77M |
| Comprehensive Income/Loss | -$198.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$198.03M |
| Other Comprehensive Income/Loss | -$5.71M |